Peter Hiestand Selected Research

Fingolimod Hydrochloride (FTY720)

7/2004	Predictability of FTY720 efficacy in experimental autoimmune encephalomyelitis by in vivo macrophage tracking: clinical implications for ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging.
6/2002	The immune modulator FTY720 targets sphingosine 1-phosphate receptors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter Hiestand Research Topics

Disease

3	Multiple Sclerosis 05/2007 - 06/2002
3	Rheumatoid Arthritis 01/2006 - 07/2004
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 05/2007 - 07/2004
2	Inflammation (Inflammations) 05/2007 - 02/2006
2	Experimental Arthritis 07/2004 - 08/2002
1	Arthritis (Polyarthritis) 07/2004
1	Autoimmune Diseases (Autoimmune Disease) 06/2002
1	Lymphopenia (Lymphocytopenia) 06/2002

Drug/Important Bio-Agent (IBA)

2	ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA 02/2006 - 07/2004
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2004 - 08/2002
2	Fingolimod Hydrochloride (FTY720)FDA Link 07/2004 - 06/2002
1	Myelin ProteinsIBA 05/2007
1	pyrimidineIBA 01/2006
1	benzocycloheptapyridineIBA 01/2006
1	PyrazinesIBA 01/2006
1	PyridinesIBA 07/2004
1	OxazolesIBA 07/2004
1	BenzophenonesIBA 07/2004
1	ImidazolesIBA 07/2004
1	ThiazolesIBA 07/2004
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 06/2002
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 06/2002
1	Immunosuppressive Agents (Immunosuppressants)IBA 06/2002
1	sphingosine kinaseIBA 06/2002

Therapy/Procedure

1	Oral Administration 01/2006
1	Organ Transplantation 06/2002